Company Registration No. 11361099 (England and Wales)
FINALBION LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
Affinia
19th Floor
1 Westfield Avenue
London
E20 1HZ
FINALBION LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
FINALBION LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023 Unaudited
Notes
£
£
£
£
Current assets
Debtors
4
279,374
556,873
Cash at bank and in hand
64,439
55,975
343,813
612,848
Creditors: amounts falling due within one year
5
(263,094)
(521,450)
Net current assets
80,719
91,398
Capital and reserves
Called up share capital
2
2
Share premium account
2,242
2,242
Profit and loss reserves
78,475
89,154
Total equity
80,719
91,398

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 12 September 2025 and are signed on its behalf by:
Mr M F Kloibhofer
Director
Company registration number 11361099 (England and Wales)
FINALBION LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information

Finalbion Limited is a private company limited by shares incorporated in England and Wales. The registered office is 19th Floor, 1 Westfield Avenue, London, E20 1HZ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Finalbion Limited is a wholly owned subsidiary of Finalbion SARL and the results of Finalbion Limited are included in the consolidated financial statements of Finalbion SARL which are available from 39, Avenue John F. Kennedy, L-1855, Luxembourg.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the true company has adequate resources to continue in operational existence for the foreseeable future. This is further supported due to the financial backing of the intermediate parent company. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recover ed.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

FINALBION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

FINALBION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -
1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023 Unaudited
Number
Number
Total
1
1
4
Debtors
2024
2023 Unaudited
Amounts falling due within one year:
£
£
Trade debtors
-
0
16,583
Amounts owed by group undertakings
10,060
10,551
Other debtors
269,314
529,739
279,374
556,873
5
Creditors: amounts falling due within one year
2024
2023 Unaudited
£
£
Amounts owed to group undertakings
4,165
4,369
Taxation and social security
7,462
22,969
Other creditors
251,467
494,112
263,094
521,450
FINALBION LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 5 -
6
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Other matters

The previous year's financial statements have not been audited.

Senior Statutory Auditor:
Richard Lane
Statutory Auditor:
Affinia (Stratford)
Date of audit report:
12 September 2025
7
Related party transactions
Transactions with related parties
Sales
Sales
2024
2023 Unaudited
£
£
Finalbion S.A.R.L
468,814
900,134

The following amounts were outstanding at the reporting end date:

2024
2023 Unaudited
Amounts due from related parties
£
£
Finalbion S.A.R.L
5,895
6,182
8
Parent company

The immediate parent company is Finalbion S.À .R.L an entity incorporated in Luxembourg, who own 100% of the shares (Company number: B196338)

As at 31st December 2024, the Directors regarded Warwick European Opportunities Fund Inc (Caymen), as the company's ultimate parent and controlling party, through a majority shareholding of the group to which the company belongs.

The smallest group into which accounts of Finalbion Limited is consolidated is Finalbion S.À .R.L. The registered office of the company is at 39 Avenue John F. Kennedy Luxembourg.

2024-12-31 2024-01-01 false false false 12 September 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Mr M J Hodgson Mr M F Kloibhofer Mr A S Mattera 11361099 2024-01-01 2024-12-31 11361099 2024-12-31 11361099 2023-12-31 11361099 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 11361099 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 11361099 core:CurrentFinancialInstruments 2024-12-31 11361099 core:CurrentFinancialInstruments 2023-12-31 11361099 core:ShareCapital 2024-12-31 11361099 core:ShareCapital 2023-12-31 11361099 core:SharePremium 2024-12-31 11361099 core:SharePremium 2023-12-31 11361099 core:RetainedEarningsAccumulatedLosses 2024-12-31 11361099 core:RetainedEarningsAccumulatedLosses 2023-12-31 11361099 bus:Director2 2024-01-01 2024-12-31 11361099 2023-01-01 2023-12-31 11361099 core:WithinOneYear 2024-12-31 11361099 core:WithinOneYear 2023-12-31 11361099 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11361099 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11361099 bus:FRS102 2024-01-01 2024-12-31 11361099 bus:Audited 2024-01-01 2024-12-31 11361099 bus:Director1 2024-01-01 2024-12-31 11361099 bus:Director3 2024-01-01 2024-12-31 11361099 bus:FullAccounts 2024-01-01 2024-12-31 xbrli:pure xbrli:shares iso4217:GBP